![Amazon.com: Nankai Pleats Designed Microfiber Origami-Animal Glasses Cloth Peti Peto 'Crane' Shape-Memory Pleated Fabric Wipe Cleaning Cloth for Eyeglasses and Smart Phone, Lens : Electronics Amazon.com: Nankai Pleats Designed Microfiber Origami-Animal Glasses Cloth Peti Peto 'Crane' Shape-Memory Pleated Fabric Wipe Cleaning Cloth for Eyeglasses and Smart Phone, Lens : Electronics](https://m.media-amazon.com/images/I/71waVe90kpL.jpg)
Amazon.com: Nankai Pleats Designed Microfiber Origami-Animal Glasses Cloth Peti Peto 'Crane' Shape-Memory Pleated Fabric Wipe Cleaning Cloth for Eyeglasses and Smart Phone, Lens : Electronics
![Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial - The Lancet Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/2119435926/2093784892/gr1.gif)
Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial - The Lancet
![What did we learn in 35 years of research on nutrition and supplements for age‐related macular degeneration: a systematic review - Pameijer - Acta Ophthalmologica - Wiley Online Library What did we learn in 35 years of research on nutrition and supplements for age‐related macular degeneration: a systematic review - Pameijer - Acta Ophthalmologica - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/4b97f4a0-f216-4e79-aa6e-bb1ce095510b/aos.v100.7.cover.jpg?trick=1667672719260)
What did we learn in 35 years of research on nutrition and supplements for age‐related macular degeneration: a systematic review - Pameijer - Acta Ophthalmologica - Wiley Online Library
![Online e-learning during the COVID-19 lockdown in Trinidad and Tobago: prevalence and associated factors with ocular complaints among schoolchildren aged 11–19 years [PeerJ] Online e-learning during the COVID-19 lockdown in Trinidad and Tobago: prevalence and associated factors with ocular complaints among schoolchildren aged 11–19 years [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2022/13334/1/fig-2-full.png)
Online e-learning during the COVID-19 lockdown in Trinidad and Tobago: prevalence and associated factors with ocular complaints among schoolchildren aged 11–19 years [PeerJ]
![Amazon.com: Nankai Pleats Designed Microfiber Origami-Animal Glasses Cloth Peti Peto 'Giraffe' Shape-Memory Pleated Fabric Wipe Cleaning Cloth for Eyeglasses and Smart Phone, Lens : Electronics Amazon.com: Nankai Pleats Designed Microfiber Origami-Animal Glasses Cloth Peti Peto 'Giraffe' Shape-Memory Pleated Fabric Wipe Cleaning Cloth for Eyeglasses and Smart Phone, Lens : Electronics](https://m.media-amazon.com/images/I/71658ZbICoL.jpg)
Amazon.com: Nankai Pleats Designed Microfiber Origami-Animal Glasses Cloth Peti Peto 'Giraffe' Shape-Memory Pleated Fabric Wipe Cleaning Cloth for Eyeglasses and Smart Phone, Lens : Electronics
![Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study - The Lancet Global Health Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study - The Lancet Global Health](https://www.thelancet.com/cms/asset/fd189741-0aaa-46f4-802d-4b3827569373/gr1.jpg)
Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study - The Lancet Global Health
![Life | Free Full-Text | Potential Properties of Natural Nutraceuticals and Antioxidants in Age-Related Eye Disorders Life | Free Full-Text | Potential Properties of Natural Nutraceuticals and Antioxidants in Age-Related Eye Disorders](https://pub.mdpi-res.com/life/life-13-00077/article_deploy/html/images/life-13-00077-g001.png?1672798422)
Life | Free Full-Text | Potential Properties of Natural Nutraceuticals and Antioxidants in Age-Related Eye Disorders
![Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials - The Lancet Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials - The Lancet](https://www.thelancet.com/cms/asset/6d79da4c-93a3-46de-af9b-484ab1913b53/gr1.jpg)
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials - The Lancet
![Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis - The Lancet Global Health Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis - The Lancet Global Health](https://www.thelancet.com/cms/attachment/e2074db1-8f43-47cb-be39-66ed651a538d/gr1.jpg)
Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis - The Lancet Global Health
![Frontiers | Non-Motor Symptoms as Predictors of Quality of Life in Egyptian Patients With Parkinson's Disease: A Cross-Sectional Study Using a Culturally Adapted 39-Item Parkinson's Disease Questionnaire Frontiers | Non-Motor Symptoms as Predictors of Quality of Life in Egyptian Patients With Parkinson's Disease: A Cross-Sectional Study Using a Culturally Adapted 39-Item Parkinson's Disease Questionnaire](https://www.frontiersin.org/files/Articles/363165/fneur-09-00357-HTML/image_m/fneur-09-00357-g001.jpg)
Frontiers | Non-Motor Symptoms as Predictors of Quality of Life in Egyptian Patients With Parkinson's Disease: A Cross-Sectional Study Using a Culturally Adapted 39-Item Parkinson's Disease Questionnaire
![The Lancet Global Health Commission on Global Eye Health: vision beyond 2020 - The Lancet Global Health The Lancet Global Health Commission on Global Eye Health: vision beyond 2020 - The Lancet Global Health](https://www.thelancet.com/cms/asset/f4779eba-fb0b-4314-b8c7-4561d92f1200/gr1.jpg)
The Lancet Global Health Commission on Global Eye Health: vision beyond 2020 - The Lancet Global Health
![Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial - The Lancet Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/ae2be8ee-317f-42d9-bfd9-4e61cc62fe4d/gr1.gif)